Piciocchi, A., Messina, M., Elia, L., Vitale, A., Soddu, S., Testi, A., et al. (2021). Prognostic impact of KMT2A-AFF1-positivity in 926 BCR-ABL1-negative B-lineage acute lymphoblastic leukemia patients treated in GIMEMA clinical trials since 1996. AMERICAN JOURNAL OF HEMATOLOGY, 96(9), 334-338 [10.1002/ajh.26253].

Prognostic impact of KMT2A-AFF1-positivity in 926 BCR-ABL1-negative B-lineage acute lymphoblastic leukemia patients treated in GIMEMA clinical trials since 1996

Cairoli R;
2021

Lettera in rivista
Adult; DNA-Binding Proteins; Female; Fusion Proteins, bcr-abl; Histone-Lysine N-Methyltransferase; Humans; Male; Myeloid-Lymphoid Leukemia Protein; Oncogene Proteins, Fusion; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Survival Analysis; Transcriptional Elongation Factors
English
2021
96
9
334
338
reserved
Piciocchi, A., Messina, M., Elia, L., Vitale, A., Soddu, S., Testi, A., et al. (2021). Prognostic impact of KMT2A-AFF1-positivity in 926 BCR-ABL1-negative B-lineage acute lymphoblastic leukemia patients treated in GIMEMA clinical trials since 1996. AMERICAN JOURNAL OF HEMATOLOGY, 96(9), 334-338 [10.1002/ajh.26253].
File in questo prodotto:
File Dimensione Formato  
Piciocchi-2021-Am J Hematol-VoR.pdf

Solo gestori archivio

Descrizione: Correspondence
Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Licenza: Tutti i diritti riservati
Dimensione 1.25 MB
Formato Adobe PDF
1.25 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/405075
Citazioni
  • Scopus 6
  • ???jsp.display-item.citation.isi??? 5
Social impact